Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gregor Zemljič"'
Autor:
Abbas Ali Qayyum, Sabina Frljak, Morten Juhl, Gregor Poglajen, Gregor Zemljičl, Andraz Cerar, Thomas Litman, Annette Ekblond, Mandana Haack‐Sørensen, Lisbeth Drozd Højgaard, Jens Kastrup, Bojan Vrtovec
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 3882-3891 (2024)
Abstract Aims Allogeneic stem cell therapy is more logistically suitable compared with autologous cell therapy for large‐scale patient treatment. We aim to investigate the clinical safety and efficacy profile of the allogeneic adipose tissue derive
Externí odkaz:
https://doaj.org/article/4efbc44cf58741399740863e39dcfb5d
Autor:
Gregor Poglajen, Gregor Zemljič, Andraž Cerar, Sabina Frljak, Martina Jaklič, Vesna Androcec, Bojan Vrtovec
Publikováno v:
Cell Transplantation, Vol 28 (2019)
Ventricular arrhythmias (VA) are of major concern in the field of cell therapy, potentially limiting its safety and efficacy. We sought to investigate the effects of CD34 + cell therapy on VA burden in patients with chronic heart failure (CHF). We pe
Externí odkaz:
https://doaj.org/article/9bb27e21679c4455b6d90136cd459a56
Autor:
Gregor Poglajen, Ajda Anžič-Drofenik, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Renata Okrajšek, Miran Šebeštjen, Bojan Vrtovec
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 522 (2020)
Background. We sought to evaluate the long-term effects of angiotensin receptor blocker–neprilysin inhibitor (ARNI) therapy on reverse remodeling of the failing myocardium in HFrEF patients. Methods. We performed a prospective non-randomized longit
Externí odkaz:
https://doaj.org/article/a64a097ff8ab44269f66379fb6f65be2
Autor:
Gregor Poglajen, Gregor Zemljič, Sabina Frljak, Andraž Cerar, Vesna Andročec, Matjaž Sever, Peter Černelč
Publikováno v:
Stem Cells International, Vol 2018 (2018)
Aim of the Review. The aim of this review is to discuss recent advances in clinical aspects of stem cell therapy in chronic nonischemic heart failure (DCMP) with emphasis on patient selection, stem cell types, and delivery methods. Recent Findings. S
Externí odkaz:
https://doaj.org/article/c8f87b658adf4c2787e23d050682982f
Autor:
Andraz Cerar, Martina Jaklic, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Barbara Guzic Salobir, Maja Dolenc Novak, Monika Stalc, Rok Zbacnik, Mirta Kozelj
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 1161-1167 (2020)
ABSTRACT Aims Non‐compaction cardiomyopathy (NCM) is a congenital heart disease characterized by an arrest of the myocardial compaction process. Although NCM patients have impaired formation of microvasculature, the functional impact of these chang
Externí odkaz:
https://doaj.org/article/3f0eea0cc3bd4b788e0955c7f1dbb76e
Autor:
Andraz Cerar, Martina Jaklic, Sabina Frljak, Gregor Poglajen, Gregor Zemljic, Barbara Guzic Salobir, Maja Dolenc Novak, Monika Stalc, Rok Zbacnik, Mirta Kozelj
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1999-2000 (2020)
Externí odkaz:
https://doaj.org/article/f19fc05b39d64b4fb2c5a121bae365bb
Autor:
Andraz Cerar, Gregor Zemljic, Sabina Frljak, Martina Jaklic, Gregor Poglajen, Matjaz Sever, Marko Cukjati, Bojan Vrtovec
Publikováno v:
Cell Transplantation, Vol 27 (2018)
Noncompaction cardiomyopathy is a rare congenital heart disorder characterized by an arrest of the myocardial compaction process. This results in the altered formation of coronary microvessels with a resulting decrease in myocardial perfusion. Transe
Externí odkaz:
https://doaj.org/article/a68dd20d129143e1b4834c9449e036d1